Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome

Annals of Neurology

Volumn 53, Issue 1, 2003, Pages 21-28

  Fukuda, Taku ^a   Motomura, Masakatsu ^a   Nakao, Yoko ^a,b   Shiraishi, Hirokazu ^a   Yoshimura, Toshiro ^c   Iwanaga, Keisuke ^b   Tsujihata, Mitsuhiro ^b   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nagasaki Kita Hospital   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; IODINE 125; OMEGA CONOTOXIN MVIIC;

ARTICLE; AUTOIMMUNITY; AUTOPSY; AUTORADIOGRAPHY; BINDING ASSAY; BINDING SITE; CEREBELLUM DEGENERATION; COMPLEX FORMATION; CONTROLLED STUDY; EATON LAMBERT SYNDROME; HUMAN; IMMUNOPRECIPITATION; MEASUREMENT; MYASTHENIA; PARANEOPLASTIC NEUROPATHY; PATHOGENESIS; PRIORITY JOURNAL; SCATCHARD PLOT;

AGED; AUTOANTIBODIES; AUTORADIOGRAPHY; CALCIUM CHANNELS, N-TYPE; CEREBELLAR ATAXIA; CEREBELLUM; ELAPID VENOMS; FEMALE; HUMANS; IODINE RADIOISOTOPES; LAMBERT-EATON MYASTHENIC SYNDROME; MALE; OMEGA-CONOTOXINS; PARANEOPLASTIC CEREBELLAR DEGENERATION;

EID: 0037236558     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10392     Document Type: Article

References (22)

1. Motomura M, Johnston I, Lang B, et al. An improved diagnostic assay for Lambett-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 1995;58:85-87.
2. Lennon VA, Kryzer TJ, Griesmann GE, et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467-1474.
3. Pinto A, Gillard S, Moss F, et al. Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons. Proc Narl Acad Sci USA 1998;95:8328-8333.
4. Dropcho EJ. Neurologic paraneoplastic syndromes. J Neurol Sci 1998;153:264-278.
5. Vincent A, Lily O, Palace J. Pathogenic auroantibodies to neuronal proteins in neurological disorders. J Neuroimmunol 1999;100:169-180.
6. Eaton LM, Lambert EH. Electromyography and electric stimulation of nerves in diseases of the motor unit. JAMA 1957;163:1117-1124.
7. Satoyoshi E, Kowa H, Fukunaga N. Subacute cerebellar degeneration and Eaton-Lambert syndrome with bronchogenic carcinoma. A case report. Neurology 1973;23:764-768.
8. Clouston PD, Saper CB, Arbizu T, et al. Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology 1992;42:1944-1950.
9. Mason WP, Graus F, Lang B, et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 1997;120:1279-1300.
10. Jun K, Piedras RE, Smith SM, et al. Ablation of P/Q-type Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)-subunit. Proc Natl Acad Sci USA 1999;96:15245-15250.
11. Fletcher CF, Tottene A, Lennon VA, et al. Dystonia and cerebellar atrophy in Cacnala null mice lacking P/Q calcium channel activity. FASEB J 2001;15:1288-1290.
12. Bourinet E, Soong TW, Sutton K, et al. Splicing of alpha 1A subunit gene generates phenotypic variants of P- and Q-type calcium channels. Nat Neurosci 1999;2:407-415.
13. Nakao YK, Motomura M, Suenaga A, et al. Specificity of omega-conotoxin MVIIC-binding and -blocking calcium channel antibodies in Lambert-Eaton myasthenic syndrome. J Neurol 1999;246:38-44.
14. Motomura M. The Lambert-Eaton myasthenic syndrome: a study of 110 Japanese cases. Rinsho Shinkeigaku 1999;39:1237-1239.
15. Black AR, Donegan CM, Denny BJ, Dolly JO. Solubilization and physical characterization of acceptors for dendrotoxin and beta-bungarotoxin from synaptic membranes of rat brain. Biochemistry 1988;27:6814-6820.
16. Awan KA, Dolly JO. K+ channel sub-types in rat brain: characteristic locations revealed using beta-bungarotoxin, alpha- and delta-dendrotoxins. Neuroscience 1991;40:29-39.
17. Filloux F, Karras J, Imperial JS, et al. The distribution of omega-conotoxin MVIICnle-binding sites in rat brain measured by autoradiography. Neurosci Lett 1994;178:263-266.
18. Gohil K, Bell JR, Ramachandran J, Miljanich GP. Neuroanatomical distribution of receptors for a novel voltage-sensitive calcium-channel antagonist, SNX-230 (omega-conopeptide MVIIC). Brain Res 1994;653:258-266.
19. Westenbroek RE, Sakurai T, Elliott EM, et al.. Immunochemical identification and subcellular distribution of the alpha 1A subunits of brain calcium channels. J Neurosci 1995;15:6403-6418.
20. Sano M, Lambert EH, McCormick DJ, Lennon VA, Muscle acetylcholine receptors complexed with autologous IgG reflect seropositivity but not necessarily in vivo binding. Neurology 1992;42:218-222.
21. Smitt PS, Kinoshita A, De Leeuw B, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med 2000;342:21-27.
22. Honnorat J, Saiz A, Giometto B, et al. Cerebellar ataxia with anti-glutamic add decarboxylase antibodies: study of 14 patients. Arch Neurol 2001;58:225-230.